Navigation Links
Vanda Pharmaceuticals Reports Second Quarter 2014 Results
Date:8/7/2014

33 

(1) Unaudited.(2) Prior year amounts have been restated to reflect a change in accounting method for the attribution of stock-based compensation. Refer to footnote 3 in the quarterly report on Form 10Q for the quarter ending June 30, 2014.(3) Non-cash stock-based compensation is allocated to both Research & development and Selling, general & administrative expenses. (4) Total Cash reflects cash, cash equivalents and marketable securities 

OPERATIONAL HIGHLIGHTSAs of August 6, 2014, over 420 new patient prescriptions have been written for HETLIOZ® in the  U.S. This represents growth of approximately 90% in new prescriptions since the Company's June 4, 2014 commercial update.  HETLIOZ® was launched in the U.S. in April 2014 for the treatment of Non-24, a disorder which affects the majority of totally blind individuals. It is estimated that approximately 80,000 Americans have the disorder.

On July 22, 2014, a new method of use patent was issued by the USPTO for HETLIOZ® in the treatment of Non-24 (patent number 8,785,492).  The '492 patent is expected to expire in 2033, potentially further extending the exclusivity protection of HETLIOZ®. In the U.S., HETLIOZ® is also covered by a composition of matter patent (patent number 5,856,529), which including a Hatch-Waxman 5-year extension is currently expected to expire in 2022.  Both patents, '529 and '492, are now listed in the FDA's Orange Book.In June 2014, the EMA accepted for evaluation Vanda's Marketing Authorization Application for oral HETLIOZ® capsules for the treatment of Non-24.
HETLIOZ® was previously granted orphan drug designation by the European Commission for the treatment of Non-24. 

Vanda has initiated development activities for the use of HETLIOZ® in the pediatric population with Non-24, as
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Vanda Pharmaceuticals Reports Third Quarter 2013 Results
2. Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013
3. Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock
4. UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
5. Vanda Pharmaceuticals Reports Second Quarter 2013 Results
6. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
7. Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
8. Vanda Pharmaceuticals, Inc. Sued by Investor
9. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
10. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
11. Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... SHANGHAI , Oct. 22, 2014   ... and WuXi PharmaTech (Cayman) Inc. (NYSE: WX ... comprehensive genomic profiling to biopharmaceutical companies conducting clinical trials ... Under the terms of the collaboration, Foundation Medicine will ... of Foundation Medicine,s FoundationOne® assay at the WuXi Genome ...
(Date:10/20/2014)... , Oct. 20, 2014  Indianapolis interventional ... Toronto -based 3D visualization leader ... Congress of Neurological Surgeons Annual Meeting that they ... for brain surgery. The collaboration is the first ... combination to improve patient outcomes. NICO,s BrainPath® interventional ...
(Date:10/20/2014)... 2014 Valeritas, Inc., a leader in simple, ... Type 2 diabetes, announced today that it has received ... award was presented October 16 th at Cardinal,s ... . The Cardinal Health Supply ... of metrics specifically targeted at the importance of developing ...
Breaking Medicine Technology:Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 3Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 4Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 5Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 2Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 3
... Presented at 9th International Symposium on,Myelodysplastic Syndromes, TAMPA, ... results,from a pivotal Phase II trial evaluating Revlimid ... myelodysplastic syndromes (MDS),were presented today by Dr. Alan ... Research Institute, at the 9th International,Symposium on MDS ...
... -- Vanda,Pharmaceuticals Inc. announced today that it will present ... annual meeting which will be held at the San,Diego ... through May,24, 2007. , The following posters will be ... in the San Diego Convention Center (Sails,Pavilion, Upper Level). ...
Cached Medicine Technology:Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 2Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 3Vanda Pharmaceuticals to Present Data on Iloperidone at the 2007,American Psychiatric Association Annual Meeting 2
(Date:10/22/2014)... (HealthDay News) -- The United States is now ... nations of West Africa land at one of ... with the virus. In a statement released ... 94 percent of air passengers from Guinea, Liberia ... these five airports -- New York City,s Kennedy ...
(Date:10/22/2014)... With the Affordable Care Act (ACA) open enrollment period starting ... Research (AIR) finds that three out of four Americans are ... percent say they are not likely or only somewhat likely ... , The AIR survey found wide gaps in Americans’ health ... how much they owe for a routine doctor’s visit. , ...
(Date:10/22/2014)... October 22, 2014 Losing Weight Your Body’s ... is staring you in the face, it certainly can be ... do your body an extra favor by doing it the ... crash diets. Instead, listen to your body, exercise regularly, and ... is essential to losing weight; you need to exercise more ...
(Date:10/22/2014)... Akeso Biomedical, Inc. , a privately held ... infections, microbial biofilms, and chronic wounds, announced that Dr. ... , Dr. Sinskey is a Professor ... of Technology, or MIT. He has been a member ... holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership ...
(Date:10/22/2014)... Tara Haelle HealthDay Reporter , ... young adult men may lead to increased blood pressure, according ... a similar rise in blood pressure for young adult women ... young adult women drank lightly or moderately, their risk of ... "This finding parallels studies in older adult men and ...
Breaking Medicine News(10 mins):Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4
... treatment against colon and ovarian cancer, including cancerous cells that ... the University of Warwick and the University of Leeds. ... Chemistry , showed that a range of compounds containing the ... the same part of the periodic table as precious metals ...
... Mackenroth, from the hit reality television series "Project Runway," is ... is bringing Living Positive By Design , a national ... Sunday, October 18th, Jack will participate in and speak at ... Valley Region through the AIDS Fund. The Living ...
... , Governor Crist Signs Proclamation , ORLANDO, ... 18-24th, celebrates the work of Healthcare Quality Professionals in ... Healthcare Quality Professionals are driven by the desire ... their patients, organizations and communities. They lead improvement changes ...
... die within a year of major surgery, study finds, ... post-traumatic stress disorder face an increased risk for dying ... after they have completed their service, according to a ... veterans who had major non-cardiac, non-emergency surgeries between 1998 ...
... 16 Augmenix announced today that it has closed a ... by Ascension Health Ventures (AHV) in St. Louis, Mo., with ... Also participating were Catalyst Health Ventures and several private ... traditionally been of a large capital equipment mindset in solving ...
... following is attributed to J. Patrick Boyle, President and CEO, ... the Minnesota State Fair may have screened positive for the ... to have confirmatory results within the next few days. This ... can contract influenza viruses. , Experts have said unequivocally that ...
Cached Medicine News:Health News:Metals could forge new cancer drug 2Health News:'Project Runway' Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design 2Health News:'Project Runway' Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design 3Health News:Florida Celebrates National Healthcare Quality Week 2Health News:Post-Traumatic Stress May Raise Death Risks 2Health News:Augmenix, Inc. Closes $6.1 Million Financing 2
... One glance at the Parasol Punctal Occluder ... product which offers several distinct advantages to ... to Insert. The Parasol's hollow nose collapses ... dilation in most cases. It's easier on ...
Extended Duration absorbable plugs are designed to provide patient comfort for up to 3 months. This long lasting plug is effective and economical for transient dry eye symptoms following surgery. Ext...
... Prevail's steerable tip, along with various fixed-shape ... the curve you need, when you need ... of the cardiac venous anatomy, adjust course ... Adjust curve and reach by telescoping ...
Attain LV Leads. Navigate minimally angled veins with little to moderate tortuosity....
Medicine Products: